ClearPoint Neuro, Inc. financial data

Symbol
CLPT on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
120 S. Sierra Avenue, Suite 100, Solana Beach, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
MRI INTERVENTIONS, INC. (to 2/11/2020), SURGIVISION INC (to 10/22/2010), SURGI VISION INC (to 5/2/2007)
Latest financial report
10-K - Q4 2024 - Feb 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 325 % -48.7%
Quick Ratio 60.1 % -57.7%
Debt-to-equity 53.3 % -29.2%
Return On Equity -62.5 % +25.6%
Return On Assets -40.8 % +14.9%
Operating Margin -62.9 % +32.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.6M shares +2.43%
Common Stock, Shares, Outstanding 27.6M shares +12%
Entity Public Float 145M USD -6.45%
Common Stock, Value, Issued 276K USD +11.7%
Weighted Average Number of Shares Outstanding, Basic 27M shares +9.85%
Weighted Average Number of Shares Outstanding, Diluted 27M shares +9.85%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 31.4M USD +31%
Revenue from Contract with Customer, Excluding Assessed Tax 31.4M USD +31%
Cost of Revenue 12.3M USD +18.6%
Research and Development Expense 12.4M USD +5.83%
Selling and Marketing Expense 14.5M USD +15%
Operating Income (Loss) -19.7M USD +12%
Net Income (Loss) Attributable to Parent -18.9M USD +14.4%
Earnings Per Share, Basic -0.7 USD/shares +22.2%
Earnings Per Share, Diluted -0.7 USD/shares +22.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 20.1M USD -13.1%
Accounts Receivable, after Allowance for Credit Loss, Current 4.71M USD +46.8%
Inventory, Net 6.86M USD -13.2%
Assets, Current 33.4M USD -7.77%
Property, Plant and Equipment, Net 2.01M USD +44.3%
Operating Lease, Right-of-Use Asset 3.09M USD -13.4%
Other Assets, Noncurrent 148K USD +35.8%
Assets 39.2M USD -8.14%
Accounts Payable, Current 1.34M USD +241%
Employee-related Liabilities, Current 4.89M USD +65.8%
Liabilities, Current 10.4M USD +39.3%
Operating Lease, Liability, Noncurrent 3.01M USD -15.6%
Liabilities 13.8M USD -35.8%
Retained Earnings (Accumulated Deficit) -191M USD -11%
Stockholders' Equity Attributable to Parent 25.4M USD +19.9%
Liabilities and Equity 39.2M USD -8.14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.84M USD +32.4%
Net Cash Provided by (Used in) Financing Activities 16.1M USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 90M shares 0%
Common Stock, Shares, Issued 27.6M shares +12%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12.2M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 20.1M USD -13.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 185K USD +3.35%
Deferred Tax Assets, Valuation Allowance 38.3M USD +7.03%
Deferred Tax Assets, Gross 38.3M USD +6.92%
Operating Lease, Liability 3.57M USD -10.6%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 5.48M USD -13.7%
Property, Plant and Equipment, Gross 3.35M USD +43.4%
Operating Lease, Liability, Current 557K USD +31.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 538K USD -43.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 954K USD +9.78%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.91M USD -18.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 985K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 31.8M USD +5.41%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 502K USD 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 243K USD +88.4%
Deferred Tax Assets, Net of Valuation Allowance 1K USD -97.4%
Share-based Payment Arrangement, Expense 6.91M USD +13.6%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%